1.Single Caudal Anesthesia for Total Hip Replacement in Geriatric Patients.
Yang Sik SHIN ; Kyung HUR ; Young Ran KWAK ; Chang Dong HAN
Korean Journal of Anesthesiology 1994;27(2):164-169
Caudal anesthesia for total hip replacement in geriatric patients has been evaluated clinically. The caudal epidural puncture was performed by a 22 G short needle through sacral hiatus with a lateral decubitus position. 1.5% lidocaine 20 mL and 0.5% bupivacaine 15 mL mixed with 1:200,000 epinephrine and 2 mg morphine was used as an anesthetics. The results were follows ; 1) The onset of caudal anesthesia was 7.9+/-4.5 min (2-20 min) and the duration was 4.8+/-3.0 hrs (1-12 hrs). 2) Anesthetic sensory level was not related with the patient's weight or height. 3) The failure rate including systemic toxicity was 13%. 4) The most common complication was hypotension and its incidence was 26.6%. 5) Time to first analgesics was 8.3+/-3.6 hrs. These results indicate that caudal anesthesia in lateral decubitus position is a recommendable anesthetic technique for total hip replacement in geriatric patients. However, the further studies for the determinations of the optimum dose of local anesthetics are needed.
Analgesics
;
Anesthesia, Caudal*
;
Anesthetics
;
Anesthetics, Local
;
Arthroplasty, Replacement, Hip*
;
Bupivacaine
;
Epinephrine
;
Geriatrics
;
Humans
;
Hypotension
;
Incidence
;
Lidocaine
;
Morphine
;
Needles
;
Punctures
2.Effects of Fentanyl on Relaxation in Smooth Muscle of the Rat Aorta.
Won Oak KIM ; Hae Keum KIL ; Young Ran KWAK ; Keun Wook LEE
Korean Journal of Anesthesiology 1995;28(6):739-746
The mechanism of vasodilation induced by fentanyl was investigated using isolated rat thoracic aortic rings. Rings were contracted with norepinephrine(10(-7) M, NE) and potassium chloride(40 mM, KC1) with and without endothelium Fentanyl (10(-9)-10(-5) M) produced dose-dependent relaxation and had no significant effect from endothelium(intact and denuded rings, test with 3X10(-4) M LNAME, N-nitro-L-arginine methyl ester). Pretreatment of indomethacin(2.5X10(-3) M, inhibitor of cyclooxygenase) failed to influence of cumulative dose-response curves. RD(50)(50% relaxation dose) and KC1/NE ratio as potency difference of fentanyl, verapamil(10(-8)-10(-5) M, Ca2+ channel blocker), nitroglycerin(10(-10)-10(-5) M, activator of guanylate cyclase) were not similar. Fentanyl and control(distilled water) were not demonstrated any different contraction produced by incremental addition of Ca2+ to aortic rings exposed to Ca2+ free, K+ -depolarized(100 mM KCl) solution(extracellular Ca2+ influx). But fentanyl had effect on intracellular Ca2+ release elicited by caffeine(20 mM) and NE(10(-7) M) indicated by dose-dependent inhibition of contraction in Ca2+ free solution. We conclude that, in rat aorta, fentanyl-induced relaxation is endothelium-independent but mediated by inhibition of alpha-adrenoceptors operated intracellular Ca2+ release (inhibition of contraction by NE) and caffeine-induced Ca2+ release from store.
Animals
;
Aorta*
;
Endothelium
;
Fentanyl*
;
Muscle, Smooth*
;
Potassium
;
Rats*
;
Relaxation*
;
Vasodilation
3.Alveolar Soft
Hyoun Oh CHO ; Kyung Duk KWAK ; Sung Do CHO ; Yeo Chung YOON ; Giu Ran KIM ; Young Ae HONG
The Journal of the Korean Orthopaedic Association 1989;24(3):997-1000
Alveolar soft-part sarcoma is a rare malignant neoplasm. It occurs most commonly in the deep tissue of the extremity, particularly in the anterior aspect of the thigh. It usually presents as a slow-growing, painless mass with little functional impairment. Because of the relative lack of symptoms, it may be easily overlooked. The course of the disease tends to be long but unrelenting, and local recurrences are frequent. There were no lifetime cures in the reported cases. This tumor is relatively unknown to orthopaedic surgeons, and a wider knowledge of its characteristics may lead to its more frequent recognization, Recently, two cases of alveolar soft-part sarcoma were encountered on the orthopaedic department of Dong-kang Hospital, Ulsan. In case 1, the tumor was found in the vastus lateralis muscle; and in case 2, vastus intermedius muscle. The authors will present these cases in detail to provide a glance at this very rare but more frequently recognizable tumor, the alveolar soft-part sarcorna.
Extremities
;
Quadriceps Muscle
;
Recurrence
;
Sarcoma
;
Sarcoma, Alveolar Soft Part
;
Surgeons
;
Thigh
;
Ulsan
4.Three Dimensional Spiral CT of the Tracheobronchial Tree: Determination of the Optimal Window Settings.
So Young SHIN ; Myung Kook KWAK ; Young Min KIM ; Kul Ho JUNG ; Hye Ran YOON ; In Joo CHEONG ; Chang Jun LEE
Journal of the Korean Radiological Society 1997;36(6):991-994
PURPOSE: To determine optimal window settings for measuring the inner diameter of the trachea and both mainbronchi by spiral CT. MATERIALS AND METHODS: Chest PA radiography and spiral CT scanning were performed in ten healthy adult volunteers. Three dimensional images were reconstructed (minimal threshold value : -1000HU ; maximal threshold value : from -200 to -900HU, of 50HU intervals) to measure the inner diameter of the trachea and both main bronchi. The results of 3D spiral CT were compared with those of chest radiography. RESULTS: The inner diameters of the trachea, right main bronchus, left main bronchus-I (1cm below the tracheal carina) and left mainbronchus-II (2cm below the tracheal carina) measured by chest radiograph and 3D spiral CT were not significantly different at maximal threshold values of -400 ~ -550HU, -450 ~ -550HU, -450 ~ -600HU and -500 ~ -600HU, respectively (p>0.05). The differences in the results of the two series were statistically significant at other threshold values however (p<0.05). CONCLUSION: We determined optimal window settings for measuring the inner diameter of the trachea and both main bronchi by spiral CT. The optimal maximal threshold values were somewhat different according to measured sites of the trachea and both main bronchi.
Adult
;
Bronchi
;
Humans
;
Radiography
;
Radiography, Thoracic
;
Thorax
;
Tomography, Spiral Computed*
;
Trachea
;
Volunteers
5.New targeted therapies for non-small cell lung cancer
Eun Hye LEE ; Se Hyun KWAK ; Chi Young KIM ; Hye Ran GWON ; Eun Young KIM ; Yoon Soo CHANG
Journal of the Korean Medical Association 2023;66(3):180-190
Lung cancer is representative of a high frequency and high mortality disease and ranks at the top in incidence and mortality in Korea, when excluding thyroid cancer. In this manuscript, we focused on current targeted therapies for lung cancer used widely in the medical field.Current Concepts: The majority of patients with lung cancer cannot be treated with surgery only and require chemotherapeutics or radiation therapy. Currently, classical chemotherapeutic agents, targeted agents, and immune checkpoint inhibitors are the most widely used. Recently, the Research and Development of antibody-drug conjugates is gaining attention, and this may become a more widely prescribed treatment in the future. Among the available treatment options, targeted therapy is becoming increasingly feasible and widespread for treating inoperable lung cancers, where driver mutations have been identified, and for adjuvant or neoadjuvant therapies. Next-generation sequencing (NGS) improves the ability to identify driver mutations that were previously difficult to detect and can also be performed on blood samples where no cancer tissue is available for testing. This makes it possible to identify therapeutic targets for targeted therapy more rapidly.Discussion and Conclusion: The most common type of lung cancer in Korea is adenocarcinoma, for which a driver mutation has been identified. Newly developed drugs target previously problematic mutations or cancer cell lines that have acquired resistance induced during the treatment process. The survival rate of patients with lung cancer is expected to improve with the development of tailored treatments for targets identified from the NGS data of the patient. This paper will help clinicians understand the current state of targeted therapies for lung cancer treatment.
6.Survey on the Current Status of Asthma Maintenance Therapy and the Impact of Asthma on Children and Family Life.
In Keun KWAK ; Ki Hyun LIM ; Young Ho KIM ; Do Yun KONG ; Bok Yang PYUN ; Hae Ran LEE
Pediatric Allergy and Respiratory Disease 2005;15(4):415-426
PURPOSE: In spite of the development of asthma management guidelines, there are discrepancies between the guidelines and real management. We surveyed the insights and the real management of asthma to assess the current status of its management in Korea. METHODS: The objects of the survey were 266 parents with asthmatic children, who attended an educational lecture by the Korean World Asthma Day Project Office (KWADPO). Face to face interviews with questionnaires of 11 questions about understanding of asthma maintenance therapy, actual conditions of taking medicine and the impact of asthma on the family life were undertaken. RESULTS: The Median age of the patients was 5.2 years old and their parents' age ranged from those in their twenties to those in their forties. The number of the patients actually taking asthma maintenance medicine (40.6 percent) was a little bit lower than the level of awareness (53.0 percent). As a controller, patients are using short-acting beta2 inhalers (35.3 percent), steroid inhalers (including combination inhaler) (31.6 percent), leukotriene receptor antagonists (24.8 percent), antihistamines (25.6 percent), theophylline (2.3 percent), etc. Regular visits to hospital or clinic were done in 53.0 percent of the patients. As a controllers, oral medications (69.2 percent) was preferred to inhalers (18.0 percent) due to better compliance and easier dosage adjustment. CONCLUSION: According to the survey, asthma had negative effects on the life quality of patients and their families. Remarkable discrepancies were noticed between the guidelines and the real-world status of taking medicine in asthmatic children. It is necessary to have patients participate actively in making asthma management plans to raise their efficacy.
Asthma*
;
Child*
;
Compliance
;
Histamine Antagonists
;
Humans
;
Korea
;
Leukotriene Antagonists
;
Nebulizers and Vaporizers
;
Parents
;
Quality of Life
;
Surveys and Questionnaires
;
Theophylline
7.Difference of Regional Lung density in Inspiration and Expiration CT.
Young Min KIM ; Byung Kook KWAK ; Sang Kyu YANG ; Hyun Sun PARK ; Hye Ran YOON ; In Ju JUNG ; Chang Joon LEE
Journal of the Korean Radiological Society 1997;36(6):983-986
PURPOSE: To evaluate differences in regional density of normal lung, as seen on CT, according to respiration and gravity. MATERIALS AND METHODS: The subjects were 15 healthy volunteers, all non-smokers and without previous pulmonary disease. CT scans were obtained at three selected levels through the apex, middle and basal lung at the aortic arch, carina and just above the diaphragm, respectively at both full inspiration (FVC) and full expiration (RV). Within these regions of interest and at the three scanning levels, lung density was measured in the anterior, lateral, and posterior portions of the peripheral lung field. RESULTS: Attenuation of the anterior portion of the lung was lower than that of the posterior portion(p<0.005); average lung attenuation increase from the anterior to the posterior portion was significantly greater during full expiration than full inspiration (p<0.005), and was significantly greater at the base of the lung than at the apex (p<0.005 on expiration, p=0.006 on inspiration). Lung density during inspiration was lower than during expiration (p<0.005); average lung density increase from full inspiration to full expiration was significantly greater in the posterior portion than in the anterior (p<0.005). In the former, the average increase at the base of the lung was greater than at the apex (p=0.007), but in the latter, the average increase at the apex was greater than at thebase (p<0.005). CONCLUSION: In normal lung, respiration and gravity cause regional density changes, as seen on CT, and result in difference of lung attenuation between dependent and nondependent portions and between the apex, middle and base of the lung, according to inspiration and expiration.
Aorta, Thoracic
;
Diaphragm
;
Gravitation
;
Healthy Volunteers
;
Lung Diseases
;
Lung*
;
Respiration
;
Tomography, X-Ray Computed
8.Severity Scoring of Atopic Dermatitis in Children: Study for Usefulness of Three Item Severity Score.
Kyung Eun LEE ; In Keun KWAK ; Young Ho KIM ; Ji Ah JUNG ; Seung YANG ; Tae WHANG ; Hae Ran LEE
Pediatric Allergy and Respiratory Disease 2004;14(1):62-70
PURPOSE: Many different scoring systems have been proposed for assessing the severity of atopic dermatitis. The SCORAD (SCORing Atopic Dermatitis) is one of the best validated systems, but is too complicated and time-consuming for routine clinical use. The aim of this study is to evaluate the Three Item Severity (TIS) score in routine clinical practice and to investigate the correlation with SCORAD and quality of life. METHODS: The study was done on 69 cases of atopic dermatitis randomly selected by SCORAD severity in Kangdong Sacred Heart Hospital pediatric allergy clinic from March 2003 to August 2003. Patients were from three months old to 15 years old. A trained pediatrician assessed the TIS score and simultaneous 10 item questionnaire about quality of life (QOL) was checked. RESULTS: According to the SCORAD, there were 21 (30.4%) mild cases, 26 (37.7%) moderate cases and 22 (31.9%) severe cases out of total 69 patients. According to the TIS score, 21 (30.4%) cases were 0-2 point, 16 (23.2%) were 3 point, 11 (16.0%) were 4-5 point and include 21 (30.3%) were 6-9 point. In QOL score, 21-30 points were most common (36.2%). There was significant positive correlation between TIS score and SCORAD (Spearman's rs= 0.86, P< 0.01). There was significant positive correlation between TIS score and QOL (Spearman's rs=0.89, P< 0.01). CONCLUSION: The TIS score is a reliable and simple scoring system for atopic dermatitis. It is particularly suitable in general practice, for routine clinical use.
Adolescent
;
Child*
;
Dermatitis, Atopic*
;
General Practice
;
Heart
;
Humans
;
Hypersensitivity
;
Quality of Life
;
Surveys and Questionnaires
9.The Effects of Cholestasis and Hepatic Failure on Vecuronium - induced Neuromuscular Blockade in the Cat.
Kyoung Min LEE ; Young Ran KWAK ; Yang Sik SHIN ; Ryung CHOI ; Jong Rae KIM
Korean Journal of Anesthesiology 1993;26(5):892-901
To determine th effects of experimental extrahepatic cholestasis in the pharmacodynamics of vecumnium, the author administered vecuronium 500 ug/kg intravenously to six normal cats(control group), and into each of six cats with hepatic failure (hepatic failure group) and cholestasis (cholestasis group). The hepatic failure was induced with galactosamine hydrochloride and the cholestasis with the ligation of the common bile duct and cystic duct, 16 hours and 8 days prior to the neuromuscular study, respectively. The force of the anterior tibialis muscle in response to supramaximal common peroneal nerve stimulations were recorded. The time intervals from vecuronium administration to attain 100% twitch depression (onset time), from vecumnium administration to recovery of 25% twitch tension (duration) and from 25% to 75% twitch recovery (recovery index) were compared among the three groups. The results are as follows: 1) There were no significant differences between the groups with respect to rectal temperature, heart rate and mean arterial pressure immediately before vecuronium administration. 2) According to the differences of base excesses, the pH of arterial blood was significantly lower in the hepatic failure and cholestasis groups than in the control groups. 3) After induction of the hepatic failure and cholestasis group, SGOT, SGPT and prothrombin time were significantly increased when compared to the preinduction data in the two groups and data from the control group. Total bilirubin, BUN and creatinine concentration after cholestasis was significantly higher than those of the control group and the hepatic failure group. 4) The onset time in the hepatic failure and cholestasis group was slightly prolonged as compared with that in the control group. However, there was no statistical significance. The duration was significantly longer in hepatic failure and cholestasis than in the control group, and also the recovery index was significantly increased in the hepatic failure and cholestasis groups, as compared with the control group, There were no significant differences between the hepatic failure and cholestasis groups. These vesults indicate that experimental extrahepatic cholestasis induced by complete obstruction of biliary tract prolongs the duration and recovery index of vecuronium, and the effects may be caused by the impairment of direct biliary excretion, hepatic dysfunction and renal impairment.
Alanine Transaminase
;
Animals
;
Arterial Pressure
;
Aspartate Aminotransferases
;
Biliary Tract
;
Bilirubin
;
Cats*
;
Cholestasis*
;
Cholestasis, Extrahepatic
;
Common Bile Duct
;
Creatinine
;
Cystic Duct
;
Depression
;
Galactosamine
;
Heart Rate
;
Hydrogen-Ion Concentration
;
Ligation
;
Liver Failure*
;
Neuromuscular Blockade*
;
Peroneal Nerve
;
Prothrombin Time
;
Vecuronium Bromide*
10.Safety and Efficacy of Peroxisome Proliferator-Activated Receptor-alpha Agonist for Treating Cardiovascular Disease.
Young Ran KANG ; Choong Hwan KWAK ; Jin Yong HWANG
Korean Circulation Journal 2007;37(12):599-608
Peroxisome proliferator-activated receptor (PPAR)-alpha belongs to the nuclear family of ligand-activated transcriptional factors. The main role of PPAR-alpha is to activate the expression of the genes that are involved in fatty acid oxidation to achieve energy homeostasis. Fibrates are a known class of PPAR-alpha agonists, and they been used clinically for their effects of lowering triglycerides and elevating high-density lipoprotein-cholesterol (HDL-C). Further, recent experimental studies have demonstrated the anti-inflammatory and anti-atherosclerotic actions of PPAR-alpha agonists directly on the vascular wall. PPAR agonists are currently emerging as a promising therapeutic option to control systemic and vascular atherogenic factors. Regardless of their strong anti-atherosclerotic properties, large clinical studies have demonstrated inconsistent results for the cardioprotective effect of PPAR-alpha agonists; moreover, it has been observed that they did not decrease the total mortality, which stands in contrast to the statin trials. This review summarizes the current knowledge regarding the PPAR biology and the mechanisms of the effects of PPAR-alpha on lipid metabolism, the vessel wall and the cardiac metabolism. We also describe the results and lessons learned from the important clinical trials of PPAR-alpha agonists and we discuss these drugs' efficacy and safety.
Biology
;
Cardiovascular Diseases*
;
Fibric Acids
;
Homeostasis
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Lipid Metabolism
;
Metabolism
;
Mortality
;
Nuclear Family
;
Peroxisome Proliferator-Activated Receptors
;
Peroxisomes*
;
Triglycerides